On March 12, 2025, Xie Jun, Deputy District Governor of Jiangbei District, and Dai Xuerong, Director of the Jiangbei District Bureau of Science and Technology, visited Zhejiang Tianyuan Biotechnology Co., Ltd. (hereinafter referred to as "Tianyuan Biotech") for an inspection tour. They gained in-depth insights into the company’s innovative advancements and strategic vision in the health sector. Huang Bisheng, Chairman of Tianyuan Biotech, and Zhu Youwu, Group Administrative Director, accompanied the delegation throughout the visit, discussing regional economic growth and the future of health initiatives.

     The delegation first toured Tianyuan Biotech’s scientific research exhibition hall and laboratories. Chairman Huang Bisheng provided a detailed introduction to the company’s technological breakthroughs and practical applications in cutting-edge fields such as stem cell and immune cell storage, as well as genetic testing. At the cell storage facility, Deputy District Governor Xie Jun attentively listened to explanations about the principles and processes of cell preservation, praising Tianyuan Biotech’s advanced cryopreservation technology and rigorous quality control systems. Chairman Huang emphasized that cell storage not only safeguards individual health but also preserves critical biological resources for future medical advancements.

     During the visit, Huang Bisheng elaborated on Tianyuan Biotech’s core philosophy of "whole-life-cycle health services." The company is committed to creating a closed-loop system for cell therapy and health management that spans all stages of life. By integrating technologies across genetic testing, cell research, and clinical applications, Tianyuan Biotech delivers precise and personalized health solutions. To date, the company has established strategic partnerships with numerous renowned domestic and international research institutions and top-tier hospitals, aiming to build a comprehensive industrial chain from foundational research to clinical translation.

     Deputy District Governor Xie Jun spoke highly of Tianyuan Biotech’s achievements in technological innovation and health services. He remarked that as a leading high-tech enterprise in the region, Tianyuan Biotech’s development model and innovation capabilities set a benchmark for the district’s health industry. The government, he stated, will continue to support the company’s growth by providing favorable policies and resource platforms. He also encouraged Tianyuan Biotech to expand its R&D investments, strengthen global engagement, and actively participate in shaping industry standards to elevate the district’s industrial influence nationally and internationally.

     Dai Xuerong, Director of the District Bureau of Science and Technology, noted that Tianyuan Biotech’s innovative trajectory aligns closely with the region’s scientific and technological strategy. Moving forward, the bureau will offer increased guidance and support in areas such as research project applications and talent development, helping the company overcome key technical challenges in cell therapy and accelerate the commercialization of scientific achievements.

     Looking ahead, Chairman Huang Bisheng expressed that with strong governmental support, Tianyuan Biotech will remain steadfast in its mission to "harness the essence of science to protect human health." The company plans to further advance its testing and R&D capabilities while deepening industry-academia-hospital collaborations to build a broader innovation ecosystem for life sciences. By refining its "whole-life-cycle health services" framework, Tianyuan Biotech aims to deliver high-quality, comprehensive health solutions to more individuals, driving the regional health industry to new heights and contributing to the national Healthy China strategy.